Binding characteristics of the 5-HT2A receptor antagonists altanserin and MDL 100907.

Binding characteristics of the 5-HT2A receptor antagonists altanserin and MDL 100907.

Item
http://www.wikidata.org/entity/Q34457050
Radiosynthesis and in vivo evaluation of a series of substituted 11C-phenethylamines as 5-HT (2A) agonist PET tracers.5-HT radioligands for human brain imaging with PET and SPECTExtended characterisation of the serotonin 2A (5-HT2A) receptor-selective PET radiotracer 11C-MDL100907 in humans: quantitative analysis, test-retest reproducibility, and vulnerability to endogenous 5-HT tone.The neuropharmacology of prolactin secretion elicited by 3,4-methylenedioxymethamphetamine ("ecstasy"): a concurrent microdialysis and plasma analysis study.Sustained recreational use of ecstasy is associated with altered pre and postsynaptic markers of serotonin transmission in neocortical areas: a PET study with [¹¹C]DASB and [¹¹C]MDL 100907Measuring endogenous 5-HT release by emission tomography: promises and pitfalls.Current radiosynthesis strategies for 5-HT2A receptor PET tracers.Validation and quantification of [18F]altanserin binding in the rat brain using blood input and reference tissue modeling.Suitability of [18F]altanserin and PET to determine 5-HT2A receptor availability in the rat brain: in vivo and in vitro validation of invasive and non-invasive kinetic models.Neocortical serotonin2A receptor binding predicts quetiapine associated weight gain in antipsychotic-naive first-episode schizophrenia patients.Synthesis, radiofluorination, and preliminary evaluation of the potential 5-HT2A receptor agonists [18 F]Cimbi-92 and [18 F]Cimbi-150.Similar serotonin-2A receptor binding in rats with different coping styles or levels of aggression.Analysis of 5-HT(2A) receptor binding with [(11)C]MDL 100907 in rats: optimization of kinetic modeling.Serotonin2A receptor blockade and clinical effect in first-episode schizophrenia patients treated with quetiapine.Kinetic analysis of [F] altanserin bolus injection in the canine brain using PET imaging
P2860

Binding characteristics of the 5-HT2A receptor antagonists altanserin and MDL 100907.

Item
http://www.wikidata.org/entity/Q34457050
description
2005 nî lūn-bûn
@nan
2005 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Binding characteristics of the 5-HT2A receptor antagonists altanserin and MDL 100907.
@ast
Binding characteristics of the 5-HT2A receptor antagonists altanserin and MDL 100907.
@en
Binding characteristics of the 5-HT2A receptor antagonists altanserin and MDL 100907.
@nl
type
label
Binding characteristics of the 5-HT2A receptor antagonists altanserin and MDL 100907.
@ast
Binding characteristics of the 5-HT2A receptor antagonists altanserin and MDL 100907.
@en
Binding characteristics of the 5-HT2A receptor antagonists altanserin and MDL 100907.
@nl
prefLabel
Binding characteristics of the 5-HT2A receptor antagonists altanserin and MDL 100907.
@ast
Binding characteristics of the 5-HT2A receptor antagonists altanserin and MDL 100907.
@en
Binding characteristics of the 5-HT2A receptor antagonists altanserin and MDL 100907.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P698
P356
P1433
P1476
Binding characteristics of the 5-HT2A receptor antagonists altanserin and MDL 100907.
@en
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P698